Epidemiological Features and Clinical Presentations of Acute Coronary Syndrome in Young Patients.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 May 2020
Historique:
pubmed: 14 2 2020
medline: 6 10 2020
entrez: 14 2 2020
Statut: ppublish

Résumé

Objective Although acute coronary syndrome (ACS) is an uncommon entity in young patients, it constitutes an important problem due to the devastating effects of the disease on the more active lifestyle of young patients. At present, there are no guidelines regarding the prevention of ACS in young patients. Methods We performed a retrospective study of ACS patients between 2014 and 2017. Epidemiological data, clinical findings, and short-term outcomes were evaluated between young ACS patients (≤50 years old) and elderly ACS patients (>50 years old). Results Of a total of 361 consecutive ACS patients, 37 were young ACS patients (10.2%). Compared with elderly ACS patients, young ACS patients showed a higher prevalence of males (94.6% vs. 73.8%, p<0.001), current smoking (70.3% vs. 29.9%; p<0.001), and overweight persons (67.6% vs. 27.8%, p<0.001). The eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratio was significantly lower in young ACS patients than in elderly ACS patients [0.17 (0.12-0.25) vs. 0.25 (0.18-0.37), p=0.002]. The prevalence of cardio-pulmonary arrest and percutaneous cardiopulmonary support use was higher in young ACS patients than in elderly ACS patients (24.3% vs. 8.6%, p=0.003, 16.2% vs. 3.1%, p<0.001). Conclusion The features were markedly different between young ACS patients and elderly ACS patients. In young ACS patients, smoking, being overweight, and a low EPA/AA ratio were distinctive risk factors, and more serious clinical presentations were observed at the onset of ACS than in older patients.

Identifiants

pubmed: 32051385
doi: 10.2169/internalmedicine.4138-19
pmc: PMC7270760
doi:

Substances chimiques

Arachidonic Acid 27YG812J1I
eicosapentaenoic acid ethyl ester 6GC8A4PAYH
Eicosapentaenoic Acid AAN7QOV9EA

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125-1131

Références

J Cardiol. 2016 Jan;67(1):22-7
pubmed: 26359712
Am J Clin Nutr. 2006 Feb;83(2):331-42
pubmed: 16469992
J Am Heart Assoc. 2015 Jul 15;4(7):
pubmed: 26178403
Circulation. 2016 Jan 26;133(4):447-54
pubmed: 26811276
Am J Cardiol. 2014 Feb 1;113(3):441-5
pubmed: 24326273
Clin Pharmacol Ther. 2000 Apr;67(4):391-7
pubmed: 10801248
Atherosclerosis. 2011 Sep;218(1):110-6
pubmed: 21684546
Heart Vessels. 2018 May;33(5):481-488
pubmed: 29147787
Nutr J. 2015 Oct 29;14:111
pubmed: 26514181
J Cardiol. 2010 May;55(3):345-53
pubmed: 20350505
Am Heart J. 2002 Jan;143(1):56-62
pubmed: 11773912
Circ J. 2012;76(4):1024-43
pubmed: 22327033
Int J Cardiol. 2014 Oct 20;176(3):577-82
pubmed: 25305703
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
J Atheroscler Thromb. 2015;22(1):52-61
pubmed: 25132379
Circ J. 2012;76(2):423-9
pubmed: 22156311
Circulation. 2002 Jun 11;105(23):2712-8
pubmed: 12057983
Eur Heart J. 2014 Jan;35(2):116-22
pubmed: 24258072
Coron Artery Dis. 2015 Jan;26(1):60-5
pubmed: 25171387
Circ J. 2011;75(1):157-66
pubmed: 21116071
Lipids. 2013 Jul;48(7):719-27
pubmed: 23389403
J Cardiol. 2015 Aug;66(2):114-9
pubmed: 25444760
N Engl J Med. 1984 Nov 1;311(18):1144-7
pubmed: 6482932
EuroIntervention. 2014 Nov;10(7):792-8
pubmed: 25415148
Circ J. 2017 Mar 24;81(4):520-528
pubmed: 28154296
Circulation. 1992 Sep;86(3):839-48
pubmed: 1516196
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
J Cardiol. 2015 Dec;66(6):482-8
pubmed: 25805011

Auteurs

Hiroaki Sawada (H)

Department of Cardiology, Aichi Medical University, Japan.

Hirohiko Ando (H)

Department of Cardiology, Aichi Medical University, Japan.

Hiroaki Takashima (H)

Department of Cardiology, Aichi Medical University, Japan.

Katsuhisa Waseda (K)

Department of Cardiology, Aichi Medical University, Japan.

Masahiro Shimoda (M)

Department of Cardiology, Aichi Medical University, Japan.

Hirofumi Ohashi (H)

Department of Cardiology, Aichi Medical University, Japan.

Akihiro Suzuki (A)

Department of Cardiology, Aichi Medical University, Japan.

Shinichiro Sakurai (S)

Department of Cardiology, Aichi Medical University, Japan.

Yusuke Nakano (Y)

Department of Cardiology, Aichi Medical University, Japan.

Tetsuya Amano (T)

Department of Cardiology, Aichi Medical University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH